Cecilia Bonolo de Campos, David Scott, Mariano Arribas, Esther Masih-Khan, Laura Bruins, Ding Yan Wang, Zhihua Li, Safa Abdulsalam, Greg Ahmann, Shaji Kumar, Esteban Braggio, Trevor Pugh, Rafael Fonseca, Suzanne Trudel, A. Keith Stewart
{"title":"获得性FCRL5突变导致多发性骨髓瘤患者对头孢司他抗耐药","authors":"Cecilia Bonolo de Campos, David Scott, Mariano Arribas, Esther Masih-Khan, Laura Bruins, Ding Yan Wang, Zhihua Li, Safa Abdulsalam, Greg Ahmann, Shaji Kumar, Esteban Braggio, Trevor Pugh, Rafael Fonseca, Suzanne Trudel, A. Keith Stewart","doi":"10.1016/S2152-2650(25)03476-7","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Page S49"},"PeriodicalIF":2.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Acquired FCRL5 Mutation Leading to Cevostamab Resistance in Multiple Myeloma\",\"authors\":\"Cecilia Bonolo de Campos, David Scott, Mariano Arribas, Esther Masih-Khan, Laura Bruins, Ding Yan Wang, Zhihua Li, Safa Abdulsalam, Greg Ahmann, Shaji Kumar, Esteban Braggio, Trevor Pugh, Rafael Fonseca, Suzanne Trudel, A. Keith Stewart\",\"doi\":\"10.1016/S2152-2650(25)03476-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10348,\"journal\":{\"name\":\"Clinical Lymphoma, Myeloma & Leukemia\",\"volume\":\"25 \",\"pages\":\"Page S49\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma, Myeloma & Leukemia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2152265025034767\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma, Myeloma & Leukemia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2152265025034767","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
期刊介绍:
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.